Related Experiment Video
Updated: Apr 14, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and
Kaivan Vaidya1, Clare Arnott2, Anne Russell3
1Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Pulmonary vein isolation (PVI) significantly improves heart function and quality of life in patients with atrial fibrillation (AF) and congestive cardiac failure (CCF). PVI is superior to pharmacological rate control and atrioventricular junction ablation with pacemaker insertion (AVJAP) for these patients.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) frequently coexists with congestive cardiac failure (CCF).
- Multiple therapeutic strategies exist for managing AF in patients with CCF.
- Understanding the comparative efficacy of these treatments is crucial for optimizing patient outcomes.
Purpose of the Study:
- To compare the effectiveness of pulmonary vein isolation (PVI), pharmacological rate control, and atrioventricular junction ablation with pacemaker insertion (AVJAP) in patients with AF and CCF.
- To evaluate the impact of these treatments on left ventricular ejection fraction (LVEF), heart failure symptoms, and exercise capacity.
Main Methods:
- Systematic review and meta-analysis of randomized control trials (RCTs).
- Included studies compared PVI, pharmacological rate control, and AVJAP for AF treatment.
- Subgroup analysis focused on patients with CCF, assessing changes in LVEF, MLHFQ, 6MWD, and exercise time.
Main Results:
- PVI demonstrated greater improvements in LVEF and MLHFQ scores compared to pharmacological rate control in CCF patients.
- PVI also showed superior outcomes in LVEF, 6MWD, and MLHFQ scores compared to AVJAP in CCF patients.
- Pharmacological rate control and AVJAP had comparable effects on LVEF and exercise time, irrespective of cardiac function.
Conclusions:
- Pulmonary vein isolation (PVI) is recommended over AVJAP or pharmacological rate control for AF patients with CCF.
- These findings support the clinical adoption of PVI for improved outcomes in this patient population.
- PVI may be considered even for patients who have already attempted pharmacological rhythm control.
More Related Videos
11:03Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
Published on: February 26, 2013
06:48Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins
Published on: October 28, 2020
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias